The global point of care coagulation testing devices market value was USD 1.55 billion in 2022, driven by the increasing demand for early diagnosis and treatment of blood clotting disorders across the globe. The market size is anticipated to grow at a CAGR of 6.3% during the forecast period of 2023-2031 to achieve a value of USD 2.68 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Point of care coagulation testing devices are machines that help immediately examine the coagulation status of patients in real-time. Some of the point of care coagulation testing devices include blood gas analysis, viscoelastic coagulation tests, platelet function tests, and various other coagulometers. These help in assessing homeostasis and act as an important tool for individualised, factor-based, and goal-directed substitution therapy. Advantages of this testing are rapid medical decisions, fast turn around times, requirement of small specimen volumes, and avoidance of sample transport and identification issues.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on device type, the market can be divided into anticoagulation monitoring devices, platelet function monitoring devices, and viscoelastic coagulation monitoring devices, among others. Viscoelastic coagulation monitoring devices are further classified by type into thromboelastography (TEG) and rotational thromboelastometry (ROTEM). On the basis of end use, the market is segmented into hospitals and clinics, and homecare, among others. By region, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global point of care coagulation testing devices market covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.
Viscoelastic coagulation monitoring devices been dominating the market and are expected to hold a larger share in the point of care coagulation testing devices market. This is due to the proven clinical efficiency of these devices in providing information on blood clots in every phase of coagulation leading to a successful haemostasis.
Meanwhile, due to the ability of anticoagulation monitoring devices to provide rapid as well as accurate results, they accounted for a large share in the market. They are widely adopted by healthcare facilities owing to their lower cost compared to other devices and high efficacy levels.
Hospitals and clinics hold a larger share of the market for point of care coagulation testing devices. This is due to the higher rates of adoption of cutting-edge technology in these settings in comparison to homecare, and the presence of experienced medical professionals and technicians to use the point of care coagulation testing devices. The rising number of hospitalisations and patients with chronic diseases and chronic bleeding disorders are also increased in the demand for point of care coagulation testing in hospitals and clinics.
However, rising awareness among the general population regarding monitoring of bleeding disorders from at home has increased the demand and use of homecare point of care coagulation testing devices. As point of care coagulation testing devices become more user-friendly and affordable, homecare use of these devices is expected to grow in the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Medtronic, plc is an American medical device company that is known for producing therapies as well as medical devices, including revolutionary cardiac devices. Some of its products include diabetes insulin pumps and pacemakers that are battery powered and miniature. It has its headquarter in Dublin, Ireland and was founded in 1949.
Abbott Laboratories was established in 1888 and is headquartered in Illinois, United States. It is a healthcare company that designs and manufactures medical devices, among other healthcare products. It is known widely for its range of products such as diagnostic tools, diabetes and vascular devices, branded generic science-based nutritional products, and pharmaceuticals.
HemoSonics, LLC was founded in 2004 and is based in Virginia, United States. It is an in vitro diagnostics company that manufactures medical equipment and is majorly involved in the exploration of haemostasis and thrombosis. It also deals with cardiac surgery, patient blood management, cardiothoracic surgery, and orthopaedic surgery, among other medical issues.
Other market players include Siemens Healthineers AG, and F. Hoffmann-La Roche Ltd., among others.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Device Type||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Point of Care Coagulation Testing Devices Market Overview
3.1 Global Point of Care Coagulation Testing Devices Market Historical Value (2016-2022)
3.2 Global Point of Care Coagulation Testing Devices Market Forecast Value (2023-2031)
4 Global Point of Care Coagulation Testing Devices Market Landscape
4.1 Global Point of Care Coagulation Testing Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Point of Care Coagulation Testing Devices Product Landscape
4.2.1 Analysis by Device Type
4.2.2 Analysis by End User
5 Global Point of Care Coagulation Testing Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Point of Care Coagulation Testing Devices Market Segmentation
6.1 Global Point of Care Coagulation Testing Devices Market by Device Type
6.1.1 Market Overview
6.1.2 Anticoagulation Monitoring Devices
6.1.3 Platelet Function Monitoring Devices
6.1.4 Viscoelastic Coagulation Monitoring Devices
220.127.116.11 Thromboelastography (TEG)
18.104.22.168 Rotational Thromboelastometry (ROTEM)
6.2 Global Point of Care Coagulation Testing Devices Market by End User
6.2.1 Market Overview
6.2.2 Hospitals & Clinics
6.3 Global Point of Care Coagulation Testing Devices Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Point of Care Coagulation Testing Devices Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Point of Care Coagulation Testing Devices Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Point of Care Coagulation Testing Devices Market
9.1 Market Share by Country
10 Latin America Point of Care Coagulation Testing Devices Market
10.1 Market Share by Country
11 Middle East and Africa Point of Care Coagulation Testing Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Teleflex Incorporated
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 F.Hoffmann-La Roche AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Abbott Laboratories
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Siemens Healthineers
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Haemonetics Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Hemosonics, LLC
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Micropoint Bioscieces, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Sienco, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 Koninklijke Philips N.V.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
18 Global Point of Care Coagulation Testing Devices Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
In 2022, the global market point of care coagulation testing devices attained a value of USD 1.55 billion.
The market is anticipated to grow at a CAGR of 6.3% during the forecast period of 2023-2031 to reach a value of USD 2.68 billion by 2031.
The major market drivers include growing prevalence of bleeding disorders, increasing geriatric population, and need for coagulation diagnostics.
The key trends of the market are growing popularity of Thromboelastography (TEG), increasing demand for homecare testing, and rising investments for the development of advanced devices.
Key market players include Medtronic, plc, Abbott Laboratories, Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., and HemoSonics, LLC, among others.
Point of care coagulation testing devices are machines that help immediately examine the coagulation status of patients in real-time.
Point of care coagulation testing devices help in assessing homeostasis and act as an important tool for individualised, factor-based, and goal-directed substitution therapy.
The global point of care coagulation testing devices market is segmented based on device type, end use, and region.
Advantages of point of care coagulation testing are support for rapid medical decisions, fast turn-around times, requirement of small specimen volumes, and avoidance of sample transport and identification issues.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.